z-logo
Premium
Unsupervised cluster analysis of chronic rhinosinusitis with nasal polyp using routinely available clinical markers and its implication in treatment outcomes
Author(s) -
Kim JeongWhun,
Huh Gene,
Rhee ChaeSeo,
Lee Chul Hee,
Lee Jaebong,
Chung JinHang,
Cho SungWoo
Publication year - 2019
Publication title -
international forum of allergy and rhinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.503
H-Index - 46
eISSN - 2042-6984
pISSN - 2042-6976
DOI - 10.1002/alr.22221
Subject(s) - medicine , chronic rhinosinusitis , nasal polyps , cluster (spacecraft) , sinusitis , immunology , computer science , programming language
Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multidimensional disease. In this study, we performed an unsupervised cluster analysis of CRSwNP using routinely available clinical markers. Methods We conducted a retrospective review of patients treated with endoscopic sinus surgery due to medically intractable bilateral CRSwNP from 2009 to 2017. Unsupervised cluster analysis was performed using a patient's clinical features, including age, peripheral blood eosinophil, tissue eosinophilia, Lund‐Mackay computed tomography (CT) scores, ratio of the CT scores for the ethmoid sinus and maxillary sinus (E/M ratio), and comorbid asthma. Tree analysis was performed to develop a clustering algorithm. Kaplan‐Meier survival analysis was performed to determine the revision surgery–free probability corresponding to each cluster. Results Data were available on 375 patients. Patients were categorized into 6 clusters comprising 2 asthmatic clusters and 4 non‐asthmatic clusters. The labels for the 2 asthmatic clusters were: asthmatic non‐eosinophilic polyp (cluster A1) and asthmatic eosinophilic polyp (cluster A2). The labels for the 4 non‐asthmatic clusters were: non‐eosinophilic polyp with older age (cluster NA1); non‐eosinophilic pol'yp with younger age (cluster NA2); eosinophilic polyp with lower E/M ratio (cluster NA3); and eosinophilic polyp with higher E/M ratio (cluster NA4). The 4‐year revision‐free rates were 100% (cluster NA1), 80.3% (NA2), 98.0% (NA3), 66.7% (NA4), 100% (A1), and 66.7% (A2). The clusters showed statistically significant differences in terms of 4‐year revision‐free rates (log‐rank p < 0.05). Conclusion Cluster analysis identified 2 asthmatic clusters and 4 non‐asthmatic clusters in CRSwNP. Each cluster corresponded to a different clinical outcome.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom